Cypherpunk Technologies Inc.
CYPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001509745
In the last 90 days, Cypherpunk Technologies Inc. insiders filed 0 open-market purchases and 3 sales; 48 institutions reported holding it in 13F filings for Q2 2026, worth $9.13M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cypherpunk Technologies Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 3 filings
- 3 insiders, $888.9K in total
- Insiders trading
- 3
- Net value
- −$888.9K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cypherpunk Technologies Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Winklevoss Tyler Howard | 10% Owner | 29,793,414Indirect | Oct 14, 2026 | 3 |
| Winklevoss Cameron Howard | 10% Owner | 29,793,414Indirect | Oct 14, 2026 | 3 |
| Winklevoss Capital Fund, LLC | 10% Owner | 29,793,414Indirect | Oct 14, 2026 | 3 |
| Winklevoss Treasury Investments, LLC | 10% Owner | 29,793,414Indirect | Oct 14, 2026 | 3 |
| Winklevoss Capital Management, LLC | 10% Owner | 29,793,414Indirect | Oct 14, 2026 | 3 |
| McEvoy William Patrick III | Chief Investment Officer | 29,793,414Indirect | Oct 14, 2026 | 4 |
| Oei Khing Djien | Director | 0 | Sep 25, 2026 | 5 |
| Martin Patricia A. | Director | 118,750 | Sep 25, 2026 | 5 |
| Dietz Thomas John | Director | 132,500 | Aug 27, 2026 | 5 |
| Zhang Kevin | Head of Mining | – | Aug 24, 2026 | 1 |
| Richard Christian M | Director | 168,750 | Jul 2, 2026 | 4 |
| Li William | Director | 168,750 | Jul 2, 2026 | 4 |
| Onsi Douglas E | CEO,CFO,Pres.,GC,Treas.&Sec. | 106,858 | Jul 2, 2026 | 4 |
| Mashiach Nissim | Director | 168,750 | Jul 2, 2026 | 4 |
| Mirabelli Christopher | Director | 130,376 | Mar 30, 2026 | 5 |
| Cavanaugh James H | Director | 168,963 | Mar 17, 2026 | 4 |
| Loscalzo Joseph | Director | 168,750 | Mar 17, 2026 | 3 |
| Schilsky Richard | Director | 168,750 | Mar 17, 2026 | 3 |
| Lawlor Augustine | Chief Operating Officer | 19,789 | Jul 1, 2025 | 0 |
| O'Mahony John Mark | Chief Manufacturing Officer | 27,500 | Jul 1, 2025 | 0 |
| Baum Jason | Chief Scientific Officer | 15,896 | Jul 1, 2025 | 0 |
| Granfield Christine | VP, Head of Reg Affairs/Qual | 15,896 | Apr 1, 2025 | 0 |
| Sirard Cynthia | Chief Medical Officer | 27,500 | Apr 1, 2025 | 0 |
| Bertagnolli Monica | Director | – | Feb 2, 2022 | 0 |
| Edelman Joseph | 10% Owner | – | Sep 28, 2021 | 0 |
| Perceptive Advisors LLC | 10% Owner | – | Sep 28, 2021 | 0 |
| Perceptive Life Sciences Master Fund Ltd | 10% Owner | – | Sep 28, 2021 | 0 |
| BeiGene, Ltd. | 10% Owner | 7,348,437 | Sep 28, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2026 (view filing)6:14 PM ET | Sep 25 | Same day | Oei Khing DjienDirector | SSale | −168.8K | $3.92 | −$661.5K | −100.0%0 after | |
| Sep 25, 2026 (view filing)6:13 PM ET | Sep 23 | 2 days | Martin Patricia A.Director | SSale | −50.0K | $3.86 | −$193.0K | −29.6%118.8K after | |
| Aug 27, 2026 (view filing)4:30 PM ET | Aug 26 | 1 day | Dietz Thomas JohnDirector | SSale | −20.0K | $1.72 | −$34.4K | −13.1%132.5K after | |
| Mar 30, 2026 (view filing) | Mar 26 | 4 days | Mirabelli ChristopherDirector | SSale | −60.0K | $0.71 | −$42.6K | −31.5%130.4K after | |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Mirabelli ChristopherDirector | SSale | −676.3K | $3.14 | −$2.12M | −99.7%2.14K after | 2 lotsDuplicate filing |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Cavanaugh James HDirector | SSale | −261.8K | $3.14 | −$822.2K | −100.0%0 after | |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Onsi Douglas ECEO,CFO,Pres.,GC,Treas.&Sec. | SSale | −676.3K | $3.14 | −$2.12M | −99.7%2.14K after | 2 lots |
| Sep 28, 2021 (view filing)4:21 PM ET | Sep 24 | 4 days | Edelman Joseph and 2 others10% Owner | PPurchase | +3.51M | $2.85 | +$10.0M | –3.51M after | Derivative |
| Sep 28, 2021 (view filing) | Sep 24 | 4 days | BeiGene, Ltd.10% Owner | PPurchase | +2.54M | $2.85 | +$7.25M | +52.9%7.35M after |